Federal Trade Commission Cracks Down On Unproven COVID-19 Treatment

Content Curator
The Federal Trade Commission announced that it had sent warning letters to several companies that had marketed the drug thymosin alpha-1 as a purported treatment for COVID-19. The drug has never been approved the Food and Drug Administration for any condition.

The Federal Trade Commission issued warning letters to several companies that marketed an unproven drug to treat COVID-19. Sales of the non-approved drug, thymosin alpha-1, were first reported by NPR.

(Image credit: Alex Brandon/AP)